CompletedNCT00481195
Official study titleAn 8 Week Double Blind, Placebo-Controlled, Parallel Group, Fixed Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamBipolarity, DepressionMedication studyAges 18–65
- Countries
- United States, Bulgaria, Hungary, + 1 other
- Sponsor
- Cephalon
TerminatedNCT01807741
Official study titleAsenapine for Bipolar Depression
This study ended early.
In CincinnatiBipolarity, DepressionMedication studyAges 18–55
- Countries
- United States
- Sponsor
- University of Cincinnati
CompletedNCT01629355
Official study titleAuditory Brainstem Response as a Diagnostic Tool in Schizophrenia and Bipolar Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including BalsfjordBipolarity, SchizophreniaObservational studyAges 18–70
- Countries
- Norway
- Sponsor
- University Hospital of North Norway
CompletedNCT03658824
Official study titleBehavioural Activation for Bipolar Depression (BA-BD): A Case Series Evaluation
This study has finished and is no longer accepting participants.
In ExeterBipolarity, DepressionInterventional studyAges 18+
- Countries
- United Kingdom
- Sponsor
- University of Exeter
CompletedNCT02239094
Official study titleIdentification of Biosignatures for Lurasidone (Latuda) Response in Bipolar Depression
This study has finished and is no longer accepting participants.
In New YorkBipolarity, DepressionMedication studyAges 18–60
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
TerminatedNCT01506232
Official study titleBrain Activity Flow Patterns Analysis Using Evoked Response Potentials in Youth With ADHD, Bipolar Disorder, or Autism Spectrum Disorders: A Preliminary Study
This study ended early.
In CambridgeBipolarity, ADHDObservational studyAges 6–17
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT03730064
What is this study about?Researchers studied N-acetyl cysteine (NAC) to find out how it affected depression symptoms in people with bipolarity during a depressive episode.
This study has finished and is no longer accepting participants.
In New YorkBipolarity, DepressionMedication studyAges 18–60
- Countries
- United States
- Sponsor
- Martin Lan
CompletedNCT03427892
What is this study about?Researchers studied Brexpiprazole to find out how it affected depression symptoms in people with bipolarity during a depressive episode.
This study has finished and is no longer accepting participants.
In DallasBipolarity, DepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- University of Texas Southwestern Medical Center
CompletedNCT01764074
Official study titleBrief Sleep Intervention for Suicide in Bipolar Disorder
This study has finished and is no longer accepting participants.
In BostonBipolarity, SuicidalityBehavioural studyAges 18–65
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
WithdrawnNCT04430959
Official study titleA Pilot, Proof of Concept, Placebo-controlled Trial of Candesartan as an Adjunctive Treatment for Bipolar Depression
This study was withdrawn before enrollment.
In HoustonBipolarity, DepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
CompletedNCT00203567
Official study titleCarbamazepine Extended-Release for the Treatment of Bipolar Depression
This study has finished and is no longer accepting participants.
In TuscaloosaBipolarity, DepressionMedication studyAges 19–65
- Countries
- United States
- Sponsor
- Tuscaloosa Research & Education Advancement Corporation
TerminatedNCT00566111
Official study titleModulation of Glutamatergic Neurotransmission in the Treatment of Bipolar Depression
This study ended early.
In New HavenBipolarity, DepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Yale University
